vTv Therapeutics (VTVT) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
vTv Therapeutics Inc. Announces Pricing of Initial Public Offering
July 29, 2015 9:48 PM EDTHIGH POINT, N.C.--(BUSINESS WIRE)-- vTv Therapeutics Inc. (the Company) (Nasdaq: VTVT) announced today the pricing of its initial public offering of 7,812,500 shares of its Class A common stock at a price to the public of $15.00 per share. All of the shares are being offered by the Company. In addition, the Company has granted the underwriters an option to purchase up to an additional 1,171,875 shares of Class A common stock. The shares of Class A common stock are expected to begin trading on the Nasdaq Global Market on July 30, 2015, under the symbol VTVT.
... More